Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-122 open-label extension in active psoriatic arthritis after Study M14-197
2014-005527-27Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Apr 2015
- Modality
- Bispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of remtolumab in psoriatic arthritis (PsA), sponsored by AbbVie Inc. Started Apr 2015; status: completed.
02
Drugs
remtolumab
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on 2014-005527-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005527-27.